VECTORBUILDER INC

VectorBuilder Inc. specializes in the end-to-end development and manufacturing of viral vector systems and biological therapeutics, with deep expertise in adeno-associated virus (AAV) production, stable cell line generation, plasmid synthesis, and ultra-purification packaging services. The company delivers custom contract research and manufacturing solutions for gene therapy and biologics development, leveraging advanced molecular cloning, large-scale vector manufacturing, and GMP-aligned purification workflows. Their technical proficiency spans AAV8 serotype optimization, high-titer vector production, and process scalability for preclinical and clinical applications, positioning them as a niche provider for complex viral vector needs in regulated environments. VectorBuilder has established consistent relationships with the Department of Health and Human Services, delivering critical viral vector manufacturing and cell line development services for NIH-funded research initiatives, particularly through NIDDK and other divisions. They also support the Department of Veterans Affairs with targeted cloning services for therapeutic development at VA medical centers, and have provided biotechnology R&D services to NASA, indicating capability in space-relevant biological engineering applications. Their agency engagements reflect a pattern of trusted, mission-critical support in advanced biologics development. The contractor’s primary focus lies in Biological Product (Except Diagnostic) Manufacturing, where they execute complex gene therapy workflows, complemented by Research and Development in Biotechnology and Testing Laboratory Services. This places them at the intersection of gene delivery platform development and preclinical validation, serving the biopharma and government-funded biomedical research sectors with specialized CRO/CDMO capabilities. As a small business structured as a 2L entity based in Chicago, Illinois, VectorBuilder operates without federal certifications but maintains a focused presence in the federal biotech procurement landscape, serving agencies requiring high-complexity, low-volume biological manufacturing and R&D support. Their geographic location supports access to major research hubs and federal procurement networks in the Midwest.